SlideShare a Scribd company logo
ROLE OF CLINICAL PHARMACIST IN THE TREATMENT OF
HYPERTENSION DISEASE AND
MANAGEMENT.
Prepared By:
Abul Mukarim Mohd Khubayeb
ID: 522211021
Batch: 26th
M.Pharm, University of Development Alternative.
CONTENTS
 Hypertension
 Clinical approach to hypertension
 Important to control hypertension
 Symptoms
 Types
 Causes
 Diagnosis
 Can Hypertension be prevented or avoided?
 Risk factors for hypertension
 Treatment
 Medications
 Role of a clinical pharmacist
 WHO response for Hypertension
WHAT IS HYPERTENSION?
High blood pressure, also called hypertension, is blood
pressure that is higher than normal.
Blood pressure changes throughout the day based on your
activities. Having blood pressure measures consistently above
normal may result in a diagnosis of high blood pressure (or
hypertension).
The high blood pressure levels, the more risk you have for other
health problems, such as heart disease, heart attack, and stroke.
CLINICAL APPROACH TO HYPERTENSION
HISTORY
Following the documentation of hypertension, which
is confirmed after an elevated blood pressure (BP) on
at least 3 separate occasions (based on the average
of 2 or more readings taken at each of ≥2 follow-up
visits after initial screening), a detailed history should
extract the following information:
 Extent of end-organ damage (eg, heart, brain,
kidneys, eyes).
 Assessment of patients’ cardiovascular risk status.
 Exclusion of secondary causes of hypertension.
CONT..
Patients may have undiagnosed hypertension for years
without having had their BP checked. Therefore, a careful
history of end-organ damage should be obtained.
The Seventh Report of the Joint National Committee on
Prevention, Detection, Evaluation, and Treatment of High
Blood Pressure (JNC 7) identifies the following as targets
of end- organ damage:
 Heart: left ventricular hypertrophy, angina/previous
myocardial infarction, previous coronary
revascularization, and heart failure
 Brain: stroke or transient ischemic attack, dementia
 Chronic kidney disease
 Peripheral arterial disease
 Retinopathy.
CONT..
The historical and physical findings that suggest the
possibility of secondary hypertension are:
 a history of known renal disease, abdominal masses,
anemia, and urochrome pigmentation.
 A history of sweating, labile hypertension, and
palpitations suggests the diagnosis of
pheochromocytoma.
 A history of cold or heat tolerance, sweating, lack of
energy, and bradycardia or tachycardia may indicate
hypothyroidism or hyperthyroidism.
 A history of obstructive sleep apnea may be noted.
 A history of weakness suggests hyperaldosteronism.
 Kidney stones raise the possibility of
hyperparathyroidism.
PATIENT’S RELEVANT HISTORY
 Duration of hypertension.
 Previous therapies: responses and side effects.
 Family history of hypertension and cardiovascular
disease.
 Dietary and psychosocial history.
 Other risk factors: weight change, dyslipidemia,
smoking, diabetes, physical inactivity.
 Evidence of target organ damage: history of TIA,
stroke, transient blindness.
CONT..
 Evidence of secondary hypertension: history of
renal disease; change in appearance; muscle
weakness; spells of sweating, palpitations, tremor;
erratic sleep, snoring, daytime somnolence;
symptoms of hypo-or hyperthyroidism; use of
agents that may increase blood pressure.
 angina, myocardial infarction, congestive heart
failure; sexual function.
 Other comorbidities.
IMPORTANT TO CONTROL HYPERTENSION
 One of the major risk factors for cardiovascular
disease.
 31% adults in the affect with hypertension.
 Associated with developing other co-morbid
disease.
 Untreated can lead to heart failure, heart attack,
damage arteries which can prevent blood from
getting to the vital organs.
SYMPTOMS
Hypertension is called a "silent killer". Most people
with hypertension are unaware of the problem
because it may have no warning signs or symptoms.
For this reason, it is essential that blood pressure is
measured regularly.
When symptoms do occur, they can include early
morning headaches, nosebleeds, irregular heart
rhythms, vision changes, and buzzing in the ears.
Severe hypertension can cause fatigue, nausea,
vomiting, confusion, anxiety, chest pain, and muscle
tremors.
CONT…
The only way to detect hypertension is to have a
health professional measure blood pressure. Having
blood pressure measured is quick and painless.
Although individuals can measure their own blood
pressure using automated devices, an evaluation by
a health professional is important for assessment of
risk and associated conditions.
Detecting hypertension is done with a quick and
painless test of blood pressure. This can be done at
home, but a health professional can help assess any
risks or associated conditions.
TYPES OF HYPERTENSION
 Primary hypertension. This is also called essential
hypertension. It is called this when there is no
known cause for your high blood pressure. This is
the most common type of hypertension. This type of
blood pressure usually takes many years to
develop. It probably is a result of your lifestyle,
environment, and how your body changes as you
age.
CONT…
 Secondary hypertension. This is when a health
problem or medicine is causing your high blood
pressure. Things that can cause secondary
hypertension include:
 Kidney problems.
 Sleep apnea.
 Thyroid or adrenal gland problems.
 Some medicines.
CAUSES HIGH BLOOD PRESSURE?
Food, medicine, lifestyle, age, and genetics can
cause high blood pressure. Your doctor can help you
find out what might be causing yours. Common
factors that can lead to high blood pressure include:
 A diet high in salt, fat, and/or cholesterol.
 Chronic conditions such as kidney and hormone
problems, diabetes, and high cholesterol.
 Family history, especially if your parents or other
close relatives have high blood pressure.
CONT…
 Lack of physical activity.
 Older age (the older you are, the more likely you
are to have high blood pressure).
 Being overweight or obese.
 Race (non-Hispanic black people are more likely to
have high blood pressure than people of other
races).
 Some birth control medicines and other medicines.
 Stress.
 Tobacco use or drinking too much alcohol
DIAGNOSIS
High blood pressure is diagnosed with a blood
pressure monitor. This is a common test for all doctor
visits. A nurse will place a band (cuff) around your
arm. The band is attached to a small pump and a
meter. He or she will squeeze the pump. It will feel
tight around your arm. Then he or she will stop and
watch the meter. This provides the nurse with 2
numbers that make up your blood pressure. The top
number is your systolic reading. The bottom number
is your diastolic reading. You may also hear the
doctor or nurse say a blood pressure is “120 over 80.”
LABORATORY TEST
Recommended laboratory tests in the initial
evaluation of hypertensive patients. Repeat
measurements of renal function, serum electrolytes,
fasting glucose, and lipids may be obtained after the
introduction of a new antihypertensive agent and then
annually or more frequently if clinically indicated.
More extensive laboratory testing is appropriate for
patients with apparent drug resistant hypertension or
when the clinical evaluation suggests a secondary
form of hypertension.
BASIC LABORATORY TESTS
System Test
Renal Microscopic urinalysis, albumin excretion, serum
BUN and/or creatinine
Endocrine Serum sodium, potassium, calcium, TSH
Metabolic Fasting blood glucose, total cholesterol, HDL and
LDL (often computed) cholesterol, triglycerides
Others Hematocrit, electrocardiogram
BLOOD PRESSURE LEVELS
The Seventh Report of the Joint National
Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood
Pressure (2003 Guideline)
Normal systolic: less than
120 mm Hg
diastolic: less than
80 mm Hg
At Risk
(prehypertension)
systolic: 120–139
mm Hg
diastolic: 80–89 mm
Hg
High Blood Pressure
(hypertension)
systolic: 140 mm Hg
or higher
diastolic: 90 mm Hg
or higher
The American College of Cardiology/
American Heart Association Guideline
for the Prevention, Detection, Evaluation,
and Management of High Blood Pressure
in Adults (2017 Guideline)
Normal systolic: less than
120 mm Hg
diastolic: less than
80 mm Hg
Elevated systolic: 120–129
mm Hg
diastolic: less than
80 mm Hg
High Blood Pressure
(hypertension)
systolic: 130 mm Hg
or higher
diastolic: 80 mm Hg
or higher
CAN HYPERTENSION BE PREVENTED OR
AVOIDED?
If your high blood pressure is caused by lifestyle
factors, you can take steps to reduce your risk:
 Lose weight.
 Stop smoking.
 Eat properly.
 Exercise.
 Lower your salt intake.
 Reduce your alcohol consumption.
 Learn relaxation methods.
If your high blood pressure is caused by disease or the medicine you take, talk to your
doctor. He or she may be able to prescribe a different medicine. Additionally, treating
any underlying disease (such as controlling your diabetes) can help reduce your high
blood pressure.
RISK FACTORS FOR HYPERTENSION
Modifiable risk factors include unhealthy diets
(excessive salt consumption, a diet high in saturated
fat and trans fats, low intake of fruits and vegetables),
physical inactivity, consumption of tobacco and
alcohol, and being overweight or obese.
Non-modifiable risk factors include a family history of
hypertension, age over 65 years and co-existing
diseases such as diabetes or kidney disease.
TREATMENT
Changing your lifestyle can help control and manage
high blood pressure. Your doctor may recommend
that you make lifestyle changes including:
 Eating a heart-healthy diet with less salt
 Getting regular physical activity
 Maintaining a healthy weight or losing weight if
you're overweight or obese
 Limiting the amount of alcohol you drink
But sometimes lifestyle changes aren't enough. If diet
and exercise don't help, your doctor may recommend
medication to lower your blood pressure.
MEDICATIONS
The type of medication your doctor prescribes for high
blood pressure depends on your blood pressure
measurements and overall health. Two or more blood
pressure drugs often work better than one. Sometimes
finding the most effective medication or combination of
drugs is a matter of trial and error.
 You should aim for a blood pressure treatment goal of
less than 130/80 mm Hg if:
 You're a healthy adult age 65 or older.
 You're a healthy adult younger than age 65 with a 10%
or higher risk of developing cardiovascular disease in
the next 10 years.
 You have chronic kidney disease, diabetes or coronary
artery disease.
MEDICATIONS USED TO TREAT HIGH BLOOD
PRESSURE INCLUDE:
 Diuretics. Diuretics, sometimes called water pills,
are medications that help your kidneys eliminate
sodium and water from the body. These drugs are
often the first medications tried to treat high blood
pressure.
 Angiotensin-converting enzyme (ACE)
inhibitors. These medications — such as lisinopril
(Prinivil, Zestril), benazepril (Lotensin), captopril
and others — help relax blood vessels by blocking
the formation of a natural chemical that narrows
blood vessels.
CONT..
 Angiotensin II receptor blockers (ARBs). These
medications relax blood vessels by blocking the
action, not the formation, of a natural chemical that
narrows blood vessels. ARBs include candesartan
(Atacand), losartan (Cozaar) and others.
 Calcium channel blockers. These medications —
including amlodipine (Norvasc), diltiazem
(Cardizem, Tiazac, others) and others — help relax
the muscles of your blood vessels. Some slow your
heart rate. Calcium channel blockers may work
better for older people and people of African
heritage than do ACE inhibitors alone.
ADDITIONAL MEDICATIONS SOMETIMES USED
TO TREAT HYPERTENSION
If you're having trouble reaching your blood pressure
goal with combinations of the above medications,
your doctor may prescribe:
 Alpha blockers.
 Alpha-beta blockers.
 Beta blockers.
 Aldosterone antagonists.
 Renin inhibitors.
 Vasodilators.
 Central-acting agents.
TREATING RESISTANT HYPERTENSION
Treating resistant hypertension may involve many
steps, including:
 Changing your high blood pressure medications to
determine which combinations and doses work best
 Reviewing all the medications you take, including
those that you take for other conditions or buy
without a prescription
 Monitoring your blood pressure at home to see if
going to the doctor causes your blood pressure to
increase (white coat hypertension)
 Making healthy lifestyle changes, such as eating a
healthy diet with less salt, maintaining a healthy
weight and limiting alcohol
POTENTIAL FUTURE TREATMENTS
Researchers continue to study catheter-based
ultrasound and radiofrequency ablation of the
kidney's sympathetic nerves (renal denervation) as a
treatment for resistant hypertension. Early studies
showed some benefit, but more-robust studies found
that the therapy does not significantly lower blood
pressure in people with resistant hypertension. More
research is underway to determine what role, if any,
this therapy may have in treating hypertension.
ALTERNATIVE MEDICINE
Although diet and exercise are the most appropriate
tactics to lower your blood pressure, some supplements
also may help lower it. However, more research is needed
to determine the potential benefits. These supplements
include:
 Fiber, such as blond psyllium and wheat bran
 Minerals, such as magnesium, calcium and potassium
 Folic acid
 Supplements or products that increase nitric oxide or widen
blood vessels (vasodilators), such as cocoa, coenzyme Q10,
L-arginine and garlic
 Omega-3 fatty acids, found in fatty fish, high-dose fish oil
supplements and flaxseed
Researchers are also studying whether vitamin D can reduce blood
pressure, but evidence is conflicting. More research is needed.
LIFESTYLE AND HOME REMEDIES
 Eat healthy foods.
 Decrease the salt in your diet.
 Maintain a healthy weight.
 Increase physical activity.
 Limit alcohol.
 Don't smoke.
 Manage stress.
 Monitor your blood pressure at home.
 Practice relaxation or slow, deep breathing.
 Control blood pressure during pregnancy.
WHAT IS THE ROLE OF A CLINICAL
PHARMACIST?
Clinical pharmacists practice in all health care
settings and utilize in-depth knowledge of
medications and disease states to manage
medication therapy as part of a multi professional
team. Clinical pharmacists are responsible and
accountable for medication therapy and patient
outcomes.
HEALTH CARE SYSTEM
Composed of physician, pharmacist, nurses
 Physician: diagnosis, prescription, monitoring, medical care.
 Pharmacist: prescription, dispensing, counseling, monitoring,
pharmaceutical care.
 Nurse: administering, monitoring, nursing care.
Load to physician & nurse ; high due to the system of "physicians are all
in all in hospital for the treatment of patient, with the help of nurse.
FOR PRACTICING CLINICAL PHARMACY
As a clinical pharmacist should be need to complete
one of this programme:
 Competence of health care practitioners
 B.Pharm to M.Pharm to PharmD
 PharmD + Pre-registration + registration
 Residency programs
 Continuing Professional Development
 Informed general public – increased expectation
LEVEL OF ACTION OF CLINICAL PHARMACISTS
Clinical pharmacy activities may influence the correct
use of medicines at three different levels:
 Before the prescription
 Clinical trials
 Formularies
 Drug information
 Drug-related policies
DURING THE PRESCRIPTION
 Counselling activity
 Clinical pharmacists can influence the attitudes and
priorities of prescribers in their choice of correct
treatments.
 The clinical pharmacist monitors, detects and
prevents the medication related problems
 The clinical pharmacist pays special attention to the
dosage of drugs which need therapeutic monitoring
Community pharmacists can also make prescription decisions
directly, when over the counter drugs are counselled.
MEDICATION-RELATED PROBLEMS
 Untreated indications.
 Improper drug selection.
 Sub therapeutic dosage.
 Medication Failure to receive.
 Medication Over dosage.
 Adverse drug reactions.
 Drug interactions.
 Medication use without indication.
AFTER THE PRESCRIPTION IS WRITTEN.
 Counselling
 Preparation of personalized formulation
 Drug use evaluation
 Outcome research
 Pharma-coeconomic studies
FUNCTIONS OF CLINICAL PHARMACISTS
 Taking the medical history of the patient
 Patient care
 Formulation and management of drug policies
 Drug information
 Teaching & training to medical and paramedical staff
 Research and development
 Participation in drug utilization studies
 Patient counseling
 Therapeutic drug monitoring
 Drug interaction surveillance
 Adverse drug reaction reporting
 Safe use of drugs
CLINICAL PHARMACY SPECIALISTS
 Usually requires residency in a specialty area, in
addition to a pharmacy practice residency
 Job functions depend on the specialty and the
institution
 Usually has teaching and / or research
responsibilities
 Represent pharmacy for medication use meeting /
committee in specialty areas
WHO RESPONSE FOR HYPERTENSION
The World Health Organization (WHO) is supporting
countries to reduce hypertension as a public health
problem.
To support governments in strengthening the prevention
and control of cardiovascular disease, WHO and the
United States Centers for Disease Control and Prevention
(U.S. CDC) launched the Global Hearts Initiative in
September 2016, which includes the HEARTS technical
package. The six modules of the HEARTS technical
package (Healthy-lifestyle counselling, Evidence-based
treatment protocols, Access to essential medicines and
technology, Risk-based management, Team-based care,
and Systems for monitoring) provide a strategic approach
to improve cardiovascular health in countries across the
world.
CONT..
In September 2017, WHO began a partnership with
Resolve to Save Lives, an initiative of Vital Strategies, to
support national governments to implement the Global
Hearts Initiative. Other partners contributing to the Global
Hearts Initiative are: the CDC Foundation, the Global
Health Advocacy Incubator, the Johns Hopkins Bloomberg
School of Public Health, the Pan American Health
Organization (PAHO) and the U.S. CDC. Since
implementation of the programmed in 2017 in 18 low- and
middle-income countries, 3 million people have been put
on protocol-based hypertension treatment through person-
centered models of care. These programmed demonstrate
the feasibility and effectiveness of standardized
hypertension control programme.
Submitted to
Dr. Kallol Debnath
Associate Professor
Dept. Of Pharmacy, UODA.

More Related Content

Similar to Role_of_clinical_pharmacist_in_the_treatment_of_Hypertension_disease_and_management.pptx

Hypertension-ppt (1).pptx
Hypertension-ppt (1).pptxHypertension-ppt (1).pptx
Hypertension-ppt (1).pptx
jiregnaetichadako
 
Hypertension-ppt (1).pptx
Hypertension-ppt (1).pptxHypertension-ppt (1).pptx
Hypertension-ppt (1).pptx
jiregnaetichadako
 
Understanding hypertension
Understanding hypertensionUnderstanding hypertension
Understanding hypertension
Reynel Dan
 
HYPERTENSION.pptx
HYPERTENSION.pptxHYPERTENSION.pptx
HYPERTENSION.pptx
Ahad Ali
 
CONTROLLING HYPERTENSION: A BRIEF REVIEW
CONTROLLING HYPERTENSION: A BRIEF REVIEWCONTROLLING HYPERTENSION: A BRIEF REVIEW
CONTROLLING HYPERTENSION: A BRIEF REVIEW
Vignan University
 
Hypertension
HypertensionHypertension
Hypertension
salman habeeb
 
Hypertension.pdf
Hypertension.pdfHypertension.pdf
Hypertension.pdf
rrmjvnot
 
hypertension, CCF
hypertension, CCFhypertension, CCF
hypertension, CCF
ligi xavier
 
Hypertension
HypertensionHypertension
Hypertension
Cauveri Gurav
 
Accerlerated hypertension
Accerlerated hypertensionAccerlerated hypertension
Accerlerated hypertensionSachin Verma
 
Hypertention presentation by dhanya v thilakam
Hypertention presentation by dhanya v thilakamHypertention presentation by dhanya v thilakam
Hypertention presentation by dhanya v thilakamThilakam Dhanya
 
Hypertension
HypertensionHypertension
Hypertension
yuyuricci
 
Caring for Hypertension
Caring for HypertensionCaring for Hypertension
Caring for Hypertension
ConsidraCare
 
Blood-Pressure-Pamphlet.pdf
Blood-Pressure-Pamphlet.pdfBlood-Pressure-Pamphlet.pdf
Blood-Pressure-Pamphlet.pdf
Maples Care Home
 
Hypertension - Nutrition In Disease
Hypertension - Nutrition In DiseaseHypertension - Nutrition In Disease
Hypertension - Nutrition In Disease
RANJANI GUNASEKARAN
 
What is treatment of Hypertension?
What is treatment of Hypertension?What is treatment of Hypertension?
What is treatment of Hypertension?
healthuseful
 
Non communicable-diseases
Non communicable-diseasesNon communicable-diseases
Non communicable-diseases
Mahmoud Shaqria
 

Similar to Role_of_clinical_pharmacist_in_the_treatment_of_Hypertension_disease_and_management.pptx (20)

Hypertension-ppt (1).pptx
Hypertension-ppt (1).pptxHypertension-ppt (1).pptx
Hypertension-ppt (1).pptx
 
Hypertension-ppt (1).pptx
Hypertension-ppt (1).pptxHypertension-ppt (1).pptx
Hypertension-ppt (1).pptx
 
Understanding hypertension
Understanding hypertensionUnderstanding hypertension
Understanding hypertension
 
HYPERTENSION.pptx
HYPERTENSION.pptxHYPERTENSION.pptx
HYPERTENSION.pptx
 
CONTROLLING HYPERTENSION: A BRIEF REVIEW
CONTROLLING HYPERTENSION: A BRIEF REVIEWCONTROLLING HYPERTENSION: A BRIEF REVIEW
CONTROLLING HYPERTENSION: A BRIEF REVIEW
 
Hypertension
HypertensionHypertension
Hypertension
 
HTN presentation
HTN presentationHTN presentation
HTN presentation
 
Hypertension.pdf
Hypertension.pdfHypertension.pdf
Hypertension.pdf
 
hypertension, CCF
hypertension, CCFhypertension, CCF
hypertension, CCF
 
Hypertension
HypertensionHypertension
Hypertension
 
Accerlerated hypertension
Accerlerated hypertensionAccerlerated hypertension
Accerlerated hypertension
 
Hypertention presentation by dhanya v thilakam
Hypertention presentation by dhanya v thilakamHypertention presentation by dhanya v thilakam
Hypertention presentation by dhanya v thilakam
 
HTN
HTNHTN
HTN
 
Hypertension
HypertensionHypertension
Hypertension
 
Caring for Hypertension
Caring for HypertensionCaring for Hypertension
Caring for Hypertension
 
Blood-Pressure-Pamphlet.pdf
Blood-Pressure-Pamphlet.pdfBlood-Pressure-Pamphlet.pdf
Blood-Pressure-Pamphlet.pdf
 
Hypertension - Nutrition In Disease
Hypertension - Nutrition In DiseaseHypertension - Nutrition In Disease
Hypertension - Nutrition In Disease
 
Hypertensive Crisis
Hypertensive CrisisHypertensive Crisis
Hypertensive Crisis
 
What is treatment of Hypertension?
What is treatment of Hypertension?What is treatment of Hypertension?
What is treatment of Hypertension?
 
Non communicable-diseases
Non communicable-diseasesNon communicable-diseases
Non communicable-diseases
 

Recently uploaded

aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxStudents, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
EduSkills OECD
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
bennyroshan06
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
Col Mukteshwar Prasad
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
Excellence Foundation for South Sudan
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
Fundacja Rozwoju Społeczeństwa Przedsiębiorczego
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
Celine George
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
Vivekanand Anglo Vedic Academy
 

Recently uploaded (20)

aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxStudents, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
 

Role_of_clinical_pharmacist_in_the_treatment_of_Hypertension_disease_and_management.pptx

  • 1. ROLE OF CLINICAL PHARMACIST IN THE TREATMENT OF HYPERTENSION DISEASE AND MANAGEMENT. Prepared By: Abul Mukarim Mohd Khubayeb ID: 522211021 Batch: 26th M.Pharm, University of Development Alternative.
  • 2. CONTENTS  Hypertension  Clinical approach to hypertension  Important to control hypertension  Symptoms  Types  Causes  Diagnosis  Can Hypertension be prevented or avoided?  Risk factors for hypertension  Treatment  Medications  Role of a clinical pharmacist  WHO response for Hypertension
  • 3. WHAT IS HYPERTENSION? High blood pressure, also called hypertension, is blood pressure that is higher than normal. Blood pressure changes throughout the day based on your activities. Having blood pressure measures consistently above normal may result in a diagnosis of high blood pressure (or hypertension). The high blood pressure levels, the more risk you have for other health problems, such as heart disease, heart attack, and stroke.
  • 4. CLINICAL APPROACH TO HYPERTENSION HISTORY Following the documentation of hypertension, which is confirmed after an elevated blood pressure (BP) on at least 3 separate occasions (based on the average of 2 or more readings taken at each of ≥2 follow-up visits after initial screening), a detailed history should extract the following information:  Extent of end-organ damage (eg, heart, brain, kidneys, eyes).  Assessment of patients’ cardiovascular risk status.  Exclusion of secondary causes of hypertension.
  • 5. CONT.. Patients may have undiagnosed hypertension for years without having had their BP checked. Therefore, a careful history of end-organ damage should be obtained. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) identifies the following as targets of end- organ damage:  Heart: left ventricular hypertrophy, angina/previous myocardial infarction, previous coronary revascularization, and heart failure  Brain: stroke or transient ischemic attack, dementia  Chronic kidney disease  Peripheral arterial disease  Retinopathy.
  • 6. CONT.. The historical and physical findings that suggest the possibility of secondary hypertension are:  a history of known renal disease, abdominal masses, anemia, and urochrome pigmentation.  A history of sweating, labile hypertension, and palpitations suggests the diagnosis of pheochromocytoma.  A history of cold or heat tolerance, sweating, lack of energy, and bradycardia or tachycardia may indicate hypothyroidism or hyperthyroidism.  A history of obstructive sleep apnea may be noted.  A history of weakness suggests hyperaldosteronism.  Kidney stones raise the possibility of hyperparathyroidism.
  • 7. PATIENT’S RELEVANT HISTORY  Duration of hypertension.  Previous therapies: responses and side effects.  Family history of hypertension and cardiovascular disease.  Dietary and psychosocial history.  Other risk factors: weight change, dyslipidemia, smoking, diabetes, physical inactivity.  Evidence of target organ damage: history of TIA, stroke, transient blindness.
  • 8. CONT..  Evidence of secondary hypertension: history of renal disease; change in appearance; muscle weakness; spells of sweating, palpitations, tremor; erratic sleep, snoring, daytime somnolence; symptoms of hypo-or hyperthyroidism; use of agents that may increase blood pressure.  angina, myocardial infarction, congestive heart failure; sexual function.  Other comorbidities.
  • 9. IMPORTANT TO CONTROL HYPERTENSION  One of the major risk factors for cardiovascular disease.  31% adults in the affect with hypertension.  Associated with developing other co-morbid disease.  Untreated can lead to heart failure, heart attack, damage arteries which can prevent blood from getting to the vital organs.
  • 10. SYMPTOMS Hypertension is called a "silent killer". Most people with hypertension are unaware of the problem because it may have no warning signs or symptoms. For this reason, it is essential that blood pressure is measured regularly. When symptoms do occur, they can include early morning headaches, nosebleeds, irregular heart rhythms, vision changes, and buzzing in the ears. Severe hypertension can cause fatigue, nausea, vomiting, confusion, anxiety, chest pain, and muscle tremors.
  • 11. CONT… The only way to detect hypertension is to have a health professional measure blood pressure. Having blood pressure measured is quick and painless. Although individuals can measure their own blood pressure using automated devices, an evaluation by a health professional is important for assessment of risk and associated conditions. Detecting hypertension is done with a quick and painless test of blood pressure. This can be done at home, but a health professional can help assess any risks or associated conditions.
  • 12. TYPES OF HYPERTENSION  Primary hypertension. This is also called essential hypertension. It is called this when there is no known cause for your high blood pressure. This is the most common type of hypertension. This type of blood pressure usually takes many years to develop. It probably is a result of your lifestyle, environment, and how your body changes as you age.
  • 13. CONT…  Secondary hypertension. This is when a health problem or medicine is causing your high blood pressure. Things that can cause secondary hypertension include:  Kidney problems.  Sleep apnea.  Thyroid or adrenal gland problems.  Some medicines.
  • 14. CAUSES HIGH BLOOD PRESSURE? Food, medicine, lifestyle, age, and genetics can cause high blood pressure. Your doctor can help you find out what might be causing yours. Common factors that can lead to high blood pressure include:  A diet high in salt, fat, and/or cholesterol.  Chronic conditions such as kidney and hormone problems, diabetes, and high cholesterol.  Family history, especially if your parents or other close relatives have high blood pressure.
  • 15. CONT…  Lack of physical activity.  Older age (the older you are, the more likely you are to have high blood pressure).  Being overweight or obese.  Race (non-Hispanic black people are more likely to have high blood pressure than people of other races).  Some birth control medicines and other medicines.  Stress.  Tobacco use or drinking too much alcohol
  • 16. DIAGNOSIS High blood pressure is diagnosed with a blood pressure monitor. This is a common test for all doctor visits. A nurse will place a band (cuff) around your arm. The band is attached to a small pump and a meter. He or she will squeeze the pump. It will feel tight around your arm. Then he or she will stop and watch the meter. This provides the nurse with 2 numbers that make up your blood pressure. The top number is your systolic reading. The bottom number is your diastolic reading. You may also hear the doctor or nurse say a blood pressure is “120 over 80.”
  • 17. LABORATORY TEST Recommended laboratory tests in the initial evaluation of hypertensive patients. Repeat measurements of renal function, serum electrolytes, fasting glucose, and lipids may be obtained after the introduction of a new antihypertensive agent and then annually or more frequently if clinically indicated. More extensive laboratory testing is appropriate for patients with apparent drug resistant hypertension or when the clinical evaluation suggests a secondary form of hypertension.
  • 18. BASIC LABORATORY TESTS System Test Renal Microscopic urinalysis, albumin excretion, serum BUN and/or creatinine Endocrine Serum sodium, potassium, calcium, TSH Metabolic Fasting blood glucose, total cholesterol, HDL and LDL (often computed) cholesterol, triglycerides Others Hematocrit, electrocardiogram
  • 19. BLOOD PRESSURE LEVELS The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (2003 Guideline) Normal systolic: less than 120 mm Hg diastolic: less than 80 mm Hg At Risk (prehypertension) systolic: 120–139 mm Hg diastolic: 80–89 mm Hg High Blood Pressure (hypertension) systolic: 140 mm Hg or higher diastolic: 90 mm Hg or higher The American College of Cardiology/ American Heart Association Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2017 Guideline) Normal systolic: less than 120 mm Hg diastolic: less than 80 mm Hg Elevated systolic: 120–129 mm Hg diastolic: less than 80 mm Hg High Blood Pressure (hypertension) systolic: 130 mm Hg or higher diastolic: 80 mm Hg or higher
  • 20. CAN HYPERTENSION BE PREVENTED OR AVOIDED? If your high blood pressure is caused by lifestyle factors, you can take steps to reduce your risk:  Lose weight.  Stop smoking.  Eat properly.  Exercise.  Lower your salt intake.  Reduce your alcohol consumption.  Learn relaxation methods. If your high blood pressure is caused by disease or the medicine you take, talk to your doctor. He or she may be able to prescribe a different medicine. Additionally, treating any underlying disease (such as controlling your diabetes) can help reduce your high blood pressure.
  • 21. RISK FACTORS FOR HYPERTENSION Modifiable risk factors include unhealthy diets (excessive salt consumption, a diet high in saturated fat and trans fats, low intake of fruits and vegetables), physical inactivity, consumption of tobacco and alcohol, and being overweight or obese. Non-modifiable risk factors include a family history of hypertension, age over 65 years and co-existing diseases such as diabetes or kidney disease.
  • 22. TREATMENT Changing your lifestyle can help control and manage high blood pressure. Your doctor may recommend that you make lifestyle changes including:  Eating a heart-healthy diet with less salt  Getting regular physical activity  Maintaining a healthy weight or losing weight if you're overweight or obese  Limiting the amount of alcohol you drink But sometimes lifestyle changes aren't enough. If diet and exercise don't help, your doctor may recommend medication to lower your blood pressure.
  • 23. MEDICATIONS The type of medication your doctor prescribes for high blood pressure depends on your blood pressure measurements and overall health. Two or more blood pressure drugs often work better than one. Sometimes finding the most effective medication or combination of drugs is a matter of trial and error.  You should aim for a blood pressure treatment goal of less than 130/80 mm Hg if:  You're a healthy adult age 65 or older.  You're a healthy adult younger than age 65 with a 10% or higher risk of developing cardiovascular disease in the next 10 years.  You have chronic kidney disease, diabetes or coronary artery disease.
  • 24. MEDICATIONS USED TO TREAT HIGH BLOOD PRESSURE INCLUDE:  Diuretics. Diuretics, sometimes called water pills, are medications that help your kidneys eliminate sodium and water from the body. These drugs are often the first medications tried to treat high blood pressure.  Angiotensin-converting enzyme (ACE) inhibitors. These medications — such as lisinopril (Prinivil, Zestril), benazepril (Lotensin), captopril and others — help relax blood vessels by blocking the formation of a natural chemical that narrows blood vessels.
  • 25. CONT..  Angiotensin II receptor blockers (ARBs). These medications relax blood vessels by blocking the action, not the formation, of a natural chemical that narrows blood vessels. ARBs include candesartan (Atacand), losartan (Cozaar) and others.  Calcium channel blockers. These medications — including amlodipine (Norvasc), diltiazem (Cardizem, Tiazac, others) and others — help relax the muscles of your blood vessels. Some slow your heart rate. Calcium channel blockers may work better for older people and people of African heritage than do ACE inhibitors alone.
  • 26. ADDITIONAL MEDICATIONS SOMETIMES USED TO TREAT HYPERTENSION If you're having trouble reaching your blood pressure goal with combinations of the above medications, your doctor may prescribe:  Alpha blockers.  Alpha-beta blockers.  Beta blockers.  Aldosterone antagonists.  Renin inhibitors.  Vasodilators.  Central-acting agents.
  • 27. TREATING RESISTANT HYPERTENSION Treating resistant hypertension may involve many steps, including:  Changing your high blood pressure medications to determine which combinations and doses work best  Reviewing all the medications you take, including those that you take for other conditions or buy without a prescription  Monitoring your blood pressure at home to see if going to the doctor causes your blood pressure to increase (white coat hypertension)  Making healthy lifestyle changes, such as eating a healthy diet with less salt, maintaining a healthy weight and limiting alcohol
  • 28. POTENTIAL FUTURE TREATMENTS Researchers continue to study catheter-based ultrasound and radiofrequency ablation of the kidney's sympathetic nerves (renal denervation) as a treatment for resistant hypertension. Early studies showed some benefit, but more-robust studies found that the therapy does not significantly lower blood pressure in people with resistant hypertension. More research is underway to determine what role, if any, this therapy may have in treating hypertension.
  • 29. ALTERNATIVE MEDICINE Although diet and exercise are the most appropriate tactics to lower your blood pressure, some supplements also may help lower it. However, more research is needed to determine the potential benefits. These supplements include:  Fiber, such as blond psyllium and wheat bran  Minerals, such as magnesium, calcium and potassium  Folic acid  Supplements or products that increase nitric oxide or widen blood vessels (vasodilators), such as cocoa, coenzyme Q10, L-arginine and garlic  Omega-3 fatty acids, found in fatty fish, high-dose fish oil supplements and flaxseed Researchers are also studying whether vitamin D can reduce blood pressure, but evidence is conflicting. More research is needed.
  • 30. LIFESTYLE AND HOME REMEDIES  Eat healthy foods.  Decrease the salt in your diet.  Maintain a healthy weight.  Increase physical activity.  Limit alcohol.  Don't smoke.  Manage stress.  Monitor your blood pressure at home.  Practice relaxation or slow, deep breathing.  Control blood pressure during pregnancy.
  • 31. WHAT IS THE ROLE OF A CLINICAL PHARMACIST? Clinical pharmacists practice in all health care settings and utilize in-depth knowledge of medications and disease states to manage medication therapy as part of a multi professional team. Clinical pharmacists are responsible and accountable for medication therapy and patient outcomes.
  • 32. HEALTH CARE SYSTEM Composed of physician, pharmacist, nurses  Physician: diagnosis, prescription, monitoring, medical care.  Pharmacist: prescription, dispensing, counseling, monitoring, pharmaceutical care.  Nurse: administering, monitoring, nursing care. Load to physician & nurse ; high due to the system of "physicians are all in all in hospital for the treatment of patient, with the help of nurse.
  • 33. FOR PRACTICING CLINICAL PHARMACY As a clinical pharmacist should be need to complete one of this programme:  Competence of health care practitioners  B.Pharm to M.Pharm to PharmD  PharmD + Pre-registration + registration  Residency programs  Continuing Professional Development  Informed general public – increased expectation
  • 34. LEVEL OF ACTION OF CLINICAL PHARMACISTS Clinical pharmacy activities may influence the correct use of medicines at three different levels:  Before the prescription  Clinical trials  Formularies  Drug information  Drug-related policies
  • 35. DURING THE PRESCRIPTION  Counselling activity  Clinical pharmacists can influence the attitudes and priorities of prescribers in their choice of correct treatments.  The clinical pharmacist monitors, detects and prevents the medication related problems  The clinical pharmacist pays special attention to the dosage of drugs which need therapeutic monitoring Community pharmacists can also make prescription decisions directly, when over the counter drugs are counselled.
  • 36. MEDICATION-RELATED PROBLEMS  Untreated indications.  Improper drug selection.  Sub therapeutic dosage.  Medication Failure to receive.  Medication Over dosage.  Adverse drug reactions.  Drug interactions.  Medication use without indication.
  • 37. AFTER THE PRESCRIPTION IS WRITTEN.  Counselling  Preparation of personalized formulation  Drug use evaluation  Outcome research  Pharma-coeconomic studies
  • 38. FUNCTIONS OF CLINICAL PHARMACISTS  Taking the medical history of the patient  Patient care  Formulation and management of drug policies  Drug information  Teaching & training to medical and paramedical staff  Research and development  Participation in drug utilization studies  Patient counseling  Therapeutic drug monitoring  Drug interaction surveillance  Adverse drug reaction reporting  Safe use of drugs
  • 39. CLINICAL PHARMACY SPECIALISTS  Usually requires residency in a specialty area, in addition to a pharmacy practice residency  Job functions depend on the specialty and the institution  Usually has teaching and / or research responsibilities  Represent pharmacy for medication use meeting / committee in specialty areas
  • 40. WHO RESPONSE FOR HYPERTENSION The World Health Organization (WHO) is supporting countries to reduce hypertension as a public health problem. To support governments in strengthening the prevention and control of cardiovascular disease, WHO and the United States Centers for Disease Control and Prevention (U.S. CDC) launched the Global Hearts Initiative in September 2016, which includes the HEARTS technical package. The six modules of the HEARTS technical package (Healthy-lifestyle counselling, Evidence-based treatment protocols, Access to essential medicines and technology, Risk-based management, Team-based care, and Systems for monitoring) provide a strategic approach to improve cardiovascular health in countries across the world.
  • 41. CONT.. In September 2017, WHO began a partnership with Resolve to Save Lives, an initiative of Vital Strategies, to support national governments to implement the Global Hearts Initiative. Other partners contributing to the Global Hearts Initiative are: the CDC Foundation, the Global Health Advocacy Incubator, the Johns Hopkins Bloomberg School of Public Health, the Pan American Health Organization (PAHO) and the U.S. CDC. Since implementation of the programmed in 2017 in 18 low- and middle-income countries, 3 million people have been put on protocol-based hypertension treatment through person- centered models of care. These programmed demonstrate the feasibility and effectiveness of standardized hypertension control programme.
  • 42. Submitted to Dr. Kallol Debnath Associate Professor Dept. Of Pharmacy, UODA.